New Medicine Could Help People Quit Vaping

A new drug is undergoing testing that may be able to help people quit vaping. Cytisinicline is a plant-based medicine, and it is being tested in a 16-week randomized clinical trial that enrolls healthy volunteers 18 years and older. In a previous study, it was found to be effective in smoking cessation.

Nicotine is a highly addictive substance, and many young people have a difficult time quitting it. Among adults, 8.4 percent smoke cigarettes, and 5.6 million use e-cigarettes. Both types of cigarettes are associated with a higher risk of cardiovascular disease.

However, vaping is especially harmful for youth. It exposes them to a wide array of chemicals, including nicotine. Additionally, it has been linked to the development of lung disease, such as popcorn lung. The term popcorn lung came from the workers who make microwaveable popcorn.

If you want to quit smoking, the Food and Drug Administration (FDA) has approved a number of medicines. They include nicotine replacement therapy, such as gum, nasal spray, and patches. These medications may be used in conjunction with behavioral counseling to reduce nicotine cravings.

Another type of treatment is the use of a nicotine inhaler. This medication is usually administered by a healthcare provider, but can also be purchased over the counter. Most health insurance plans cover a range of treatments to help quit smoking. Other medications, such as buproprion, may also be used. Buproprion works by blocking the release of the hormones nicotine and dopamine, which provide feelings of pleasure and cause cravings.

Many teens start using e-cigarettes at a younger age than other tobacco products, and they have been shown to be more likely to begin smoking regular cigarettes. One study has found that one in 10 young adults aged 18-24 have a history of cigarette and/or e-cigarette use. But more research needs to be done to better understand the underlying causes and risks of using these substances.

Nicotine replacement therapy, which can be found over the counter, is considered a first-line treatment for adults looking to quit smoking. Using this therapy, teens can avoid nicotine peaks and troughs, and can receive a maintenance patch that delivers nicotine in a longer-lasting form.

Although no medications have been approved by the FDA for use with e-cigarettes, the National Institute on Drug Abuse has provided funding for researchers to investigate a drug that may be able to reduce withdrawal symptoms. The new drug, which is in testing, has been tested in cigarette smokers, and it has been reported to be as effective as varenicline.

A recent observational study found that varenicline might be effective in dual users. Vaping and cigarette use are known to be linked to the development of substance use disorders. Specifically, a child’s early onset of tobacco or substance use is linked to a greater lifetime risk of developing a substance use disorder.

Behavioral interventions such as cognitive behavioral therapy have been used successfully with teens to help them stop vaping. Cognitive behavioral therapy is a form of counseling that focuses on stress management and coping with cravings. Family members can support adherence to these interventions.

Related Articles

Back to top button